173 related articles for article (PubMed ID: 24124095)
1. Tetrahydroisoquinolinone-based steroidomimetic and chimeric microtubule disruptors.
Leese MP; Jourdan FL; Major MR; Dohle W; Hamel E; Ferrandis E; Fiore A; Kasprzyk PG; Potter BV
ChemMedChem; 2014 Jan; 9(1):85-108, 1. PubMed ID: 24124095
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antitubulin, and antiproliferative SAR of C3/C1-substituted tetrahydroisoquinolines.
Dohle W; Leese MP; Jourdan FL; Major MR; Bai R; Hamel E; Ferrandis E; Kasprzyk PG; Fiore A; Newman SP; Purohit A; Potter BV
ChemMedChem; 2014 Feb; 9(2):350-70. PubMed ID: 24436228
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, anti-tubulin and antiproliferative SAR of steroidomimetic dihydroisoquinolinones.
Leese MP; Jourdan FL; Major MR; Dohle W; Thomas MP; Hamel E; Ferrandis E; Mahon MF; Newman SP; Purohit A; Potter BV
ChemMedChem; 2014 Apr; 9(4):798-812. PubMed ID: 24596315
[TBL] [Abstract][Full Text] [Related]
4. Optimisation of tetrahydroisoquinoline-based chimeric microtubule disruptors.
Dohle W; Leese MP; Jourdan FL; Chapman CJ; Hamel E; Ferrandis E; Potter BV
ChemMedChem; 2014 Aug; 9(8):1783-93. PubMed ID: 24819406
[TBL] [Abstract][Full Text] [Related]
5. Biology-oriented synthesis of a tetrahydroisoquinoline-based compound collection targeting microtubule polymerization.
Zimmermann TJ; Roy S; Martinez NE; Ziegler S; Hedberg C; Waldmann H
Chembiochem; 2013 Feb; 14(3):295-300. PubMed ID: 23364933
[TBL] [Abstract][Full Text] [Related]
6. Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors.
Leese MP; Jourdan F; Dohle W; Kimberley MR; Thomas MP; Bai R; Hamel E; Ferrandis E; Potter BV
ACS Med Chem Lett; 2012 Jan; 3(1):5-9. PubMed ID: 22247790
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 1-phenyl-1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors.
Zheng CH; Chen J; Liu J; Zhou XT; Liu N; Shi D; Huang JJ; Lv JG; Zhu J; Zhou YJ
Arch Pharm (Weinheim); 2012 Jun; 345(6):454-62. PubMed ID: 22415658
[TBL] [Abstract][Full Text] [Related]
8. Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure.
Dohle W; Jourdan FL; Menchon G; Prota AE; Foster PA; Mannion P; Hamel E; Thomas MP; Kasprzyk PG; Ferrandis E; Steinmetz MO; Leese MP; Potter BVL
J Med Chem; 2018 Feb; 61(3):1031-1044. PubMed ID: 29227648
[TBL] [Abstract][Full Text] [Related]
9. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
Cai D; Qiu Z; Yao W; Liu Y; Huang H; Liao S; Luo Q; Xie L; Lin Z
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1217-29. PubMed ID: 27107592
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure.
Dohle W; Prota AE; Menchon G; Hamel E; Steinmetz MO; Potter BVL
ACS Omega; 2019 Jan; 4(1):755-764. PubMed ID: 30775645
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives as potential antitumor candidate.
Zhu P; Ye W; Li J; Zhang Y; Huang W; Cheng M; Wang Y; Zhang Y; Liu H; Zuo J
Chem Biol Drug Des; 2017 Mar; 89(3):443-455. PubMed ID: 27717183
[TBL] [Abstract][Full Text] [Related]
12. Isoquinoline-based biaryls as a robust scaffold for microtubule inhibitors.
Kraus Y; Glas C; Melzer B; Gao L; Heise C; Preuße M; Ahlfeld J; Bracher F; Thorn-Seshold O
Eur J Med Chem; 2020 Jan; 186():111865. PubMed ID: 31735573
[TBL] [Abstract][Full Text] [Related]
13. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
[TBL] [Abstract][Full Text] [Related]
14. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.
Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO
J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796
[TBL] [Abstract][Full Text] [Related]
15. An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.
Colley HE; Muthana M; Danson SJ; Jackson LV; Brett ML; Harrison J; Coole SF; Mason DP; Jennings LR; Wong M; Tulasi V; Norman D; Lockey PM; Williams L; Dossetter AG; Griffen EJ; Thompson MJ
J Med Chem; 2015 Dec; 58(23):9309-33. PubMed ID: 26580420
[TBL] [Abstract][Full Text] [Related]
16. Hydropathic analysis and biological evaluation of stilbene derivatives as colchicine site microtubule inhibitors with anti-leukemic activity.
Tripathi A; Durrant D; Lee RM; Baruchello R; Romagnoli R; Simoni D; Kellogg GE
J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1237-44. PubMed ID: 19912057
[TBL] [Abstract][Full Text] [Related]
17. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
[TBL] [Abstract][Full Text] [Related]
18. The Design, Synthesis, and Biological Activities of Pyrrole-Based Carboxamides: The Novel Tubulin Inhibitors Targeting the Colchicine-Binding Site.
Boichuk S; Galembikova A; Syuzov K; Dunaev P; Bikinieva F; Aukhadieva A; Zykova S; Igidov N; Gankova K; Novikova M; Kopnin P
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641324
[TBL] [Abstract][Full Text] [Related]
19. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
